TrialBlood advances2022

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.

J Erika Haydu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.